Overexpression of transferrin receptor CD71 and its tumorigenic properties in esophageal squamous cell carcinoma

Jemal, 2011, Global cancer statistics, CA Cancer J Clin, 61, 69, 10.3322/caac.20107

Law, 2003, Improvement in treatment results and long-term survival of patients with esophageal cancer: impact of chemoradiation and change in treatment strategy, Ann Surg, 238, 339, 10.1097/01.sla.0000086545.45918.ee

Law, 2007, The current management of esophageal cancer, Adv Surg, 41, 93, 10.1016/j.yasu.2007.05.007

Chen, 1999, An esophagogastroduodenal anastomosis model for esophageal adenocarcinogenesis in rats and enhancement by iron overload, Carcinogenesis, 20, 1801, 10.1093/carcin/20.9.1801

Cross, 2011, Meat consumption and risk of esophageal and gastric cancer in a large prospective study, Am J Gastroenterol, 106, 432, 10.1038/ajg.2010.415

Boult, 2008, Overexpression of cellular iron import proteins is associated with malignant progression of esophageal adenocarcinoma, Clin Cancer Res, 14, 379, 10.1158/1078-0432.CCR-07-1054

Desoize, 2004, Metals and metal compounds in cancer treatment, Anticancer Res, 24, 1529

Sanchez, 2006, Iron regulation and the cell cycle: identification of an iron-responsive element in the 3′-untranslated region of human cell division cycle 14A mRNA by a refined microarray-based screening strategy, J Biol Chem, 281, 22865, 10.1074/jbc.M603876200

Brookes, 2008, A role for iron in Wnt signalling, Oncogene, 27, 966, 10.1038/sj.onc.1210711

Song, 2011, Wnt inhibitor screen reveals iron dependence of β-catenin signaling in cancers, Cancer Res, 71, 7628, 10.1158/0008-5472.CAN-11-2745

Munoz, 2006, Effect of iron on the activation of the MAPK/ERK pathway in PC12 neuroblastoma cells, Biol Res, 39, 189, 10.4067/S0716-97602006000100021

Yu, 2011, Cellular iron depletion stimulates the JNK and p38 MAPK signaling transduction pathways, dissociation of ASK1-thioredoxin, and activation of ASK1, J Biol Chem, 286, 15413, 10.1074/jbc.M111.225946

Kaomongkolgit, 2008, Iron increases MMP-9 expression through activation of AP-1 via ERK/Akt pathway in human head and neck squamous carcinoma cells, Oral Oncol, 44, 587, 10.1016/j.oraloncology.2007.08.005

Kukulj, 2010, Altered iron metabolism, inflammation, transferrin receptors, and ferritin expression in non-small-cell lung cancer, Med Oncol, 27, 268, 10.1007/s12032-009-9203-2

Habashy, 2010, Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen, Breast Cancer Res Treat, 119, 283, 10.1007/s10549-009-0345-x

Jiang, 2010, Manipulation of iron transporter genes results in the suppression of human and mouse mammary adenocarcinomas, Anticancer Res, 30, 759

Magro, 2011, Aberrant expression of TfR1/CD71 in thyroid carcinomas identifies a novel potential diagnostic marker and therapeutic target, Thyroid, 21, 267, 10.1089/thy.2010.0173

Testa, 1993, The transferrin receptor, Crit Rev Oncog, 4, 241

Aisen, 2004, Transferrin receptor 1, Int J Biochem Cell Biol, 36, 2137, 10.1016/j.biocel.2004.02.007

Sargent, 2005, Structure/function overview of proteins involved in iron storage and transport, Curr Med Chem, 12, 2683, 10.2174/092986705774462969

Prutki, 2006, Altered iron metabolism, transferrin receptor 1 and ferritin in patients with colon cancer, Cancer Lett, 238, 188, 10.1016/j.canlet.2005.07.001

Wada, 2006, PIK3CA and TFRC located in 3q are new prognostic factors in esophageal squamous cell carcinoma, Ann Surg Oncol, 13, 961, 10.1245/ASO.2006.08.006

Hu, 2000, Establishment and characterization of HKESC-1, a new cancer cell line from human esophageal squamous cell carcinoma, Cancer Genet Cytogenet, 118, 112, 10.1016/S0165-4608(99)00193-4

Hu, 2002, Establishment, characterization, karyotyping, and comparative genomic hybridization analysis of HKESC-2 and HKESC-3: two newly established human esophageal squamous cell carcinoma cell lines, Cancer Genet Cytogenet, 135, 120, 10.1016/S0165-4608(01)00580-5

Tang, 2001, Establishment and characterization of a new xenograft-derived human esophageal squamous cell carcinoma cell line SLMT-1 of Chinese origin, Cancer Genet Cytogenet, 124, 36, 10.1016/S0165-4608(00)00317-4

Zhang, 2006, Cytogenetic aberrations in immortalization of esophageal epithelial cells, Cancer Genet Cytogenet, 165, 25, 10.1016/j.cancergencyto.2005.07.016

Hui, 2012, Cytoplasmic Forkhead Box M1 (FoxM1) in esophageal squamous cell carcinoma significantly correlates with pathological disease stage, World J Surg, 36, 90, 10.1007/s00268-011-1302-5

Hui, 2012, Prognostic significance of phosphorylated RON in esophageal squamous cell carcinoma, Med Oncol, 29, 1699, 10.1007/s12032-011-0112-9

Lee, 2006, Blockage of testicular connexins induced apoptosis in rat seminiferous epithelium, Apoptosis, 11, 1215, 10.1007/s10495-006-6981-2

Lee, 2010, Prognostic significance and therapeutic potential of eukaryotic translation initiation factor 5A (eIF5A) in hepatocellular carcinoma, Int J Cancer, 127, 968, 10.1002/ijc.25100

Chan, 2004, Mutant p53 expression enhances drug resistance in a hepatocellular carcinoma cell line, Cancer Chemother Pharmacol, 53, 519, 10.1007/s00280-004-0767-4

Liu, 2009, Targeting cadherin-17 inactivates Wnt signaling and inhibits tumor growth in liver carcinoma, Hepatology, 50, 1453, 10.1002/hep.23143

Hanninen, 2009, Expression of iron-related genes in human brain and brain tumors, BMC Neurosci, 10, 36, 10.1186/1471-2202-10-36

Ryschich, 2004, Transferrin receptor is a marker of malignant phenotype in human pancreatic cancer and in neuroendocrine carcinoma of the pancreas, Eur J Cancer, 40, 1418, 10.1016/j.ejca.2004.01.036

Sciot, 1988, Transferrin receptor expression in human hepatocellular carcinoma: an immunohistochemical study of 34 cases, Histopathology, 12, 53, 10.1111/j.1365-2559.1988.tb01916.x

Cmejla, 2006, A novel iron responsive element in the 3′ UTR of human MRCKα, Biochem Biophys Res Commun, 341, 158, 10.1016/j.bbrc.2005.12.155

Cmejla, 2010, Human MRCKα is regulated by cellular iron levels and interferes with transferrin iron uptake, Biochem Biophys Res Commun, 395, 163, 10.1016/j.bbrc.2010.02.148

Schaar, 2009, miR-320 targets transferrin receptor 1 (CD71) and inhibits cell proliferation, Exp Hematol, 37, 245, 10.1016/j.exphem.2008.10.002

Ford, 2013, Deferasirox (ICL670A) effectively inhibits oesophageal cancer growth in vitro and in vivo, Br J Pharmacol, 168, 1316, 10.1111/bph.12045

Loisel, 2011, Antitumour effects of single or combined monoclonal antibodies directed against membrane antigens expressed by human B cells leukaemia, Mol Cancer, 10, 42, 10.1186/1476-4598-10-42

Du, 2011, ARF triggers cell G1 arrest by a P53 independent ERK pathway, Mol Cell Biochem, 357, 415, 10.1007/s11010-011-0912-4

McCubrey, 2007, Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance, Biochim Biophys Acta, 1773, 1263, 10.1016/j.bbamcr.2006.10.001

Sahu, 2009, Benzyl isothiocyanate-mediated generation of reactive oxygen species causes cell cycle arrest and induces apoptosis via activation of MAPK in human pancreatic cancer cells, Carcinogenesis, 30, 1744, 10.1093/carcin/bgp157